INVECTYS THERAPEUTICS
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. It was founded in 2010 by Pierre Langlade Demoyen and Simon Wayne-Hobson and is based in Paris. Invectys develops a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on two highly prevalent tumor antigens: the nearly-universal tumor antigen telomerase that is critical to uncontrolled cell growth, and the HLA-G immune checkpoint expressed in over 50% of cancers.
INVECTYS THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.invectys.com
Total Employee:
11+
Status:
Active
Contact:
585-278-3001
Total Funding:
64.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Netnoids Rx Laboratories
Netnoids Rx Laboratories uses patient-derived organoid model systems to help find a cure for rare cancers.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
Date | New article |
---|---|
2022-03-01 | Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development |
Official Site Inspections
http://www.invectys.com Semrush global rank: 4.43 M Semrush visits lastest month: 2.5 K
- Host name: cluster010.hosting.ovh.net
- IP address: 213.186.33.19
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris

More informations about "Invectys Therapeutics"
About Invectys Inc.
About Invectys Inc. A biopharmaceutical company focused on cancer Invectys Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. It was founded in …See details»
Invectys Therapeutics - Crunchbase Company Profile & Funding
Invectys Therapeutics is a biopharmaceutical company focused on the development of immunotherapy approaches to treat cancer.See details»
Invectys Therapeutics - Executive Bio, Top Executies, and …
View the organization profile of Invectys Therapeutics,Dr. Jake Kushner is the President and Chief Executive Officer of Invectys, Inc. Dr. Kushner also serves as Medical Director for McNair …See details»
Invectys Therapeutics - Org Chart, Teams, Culture
View Invectys Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Invectys Company Profile - Office Locations, Competitors ... - Craft
Invectys has 5 employees across 3 locations and $4.69 m in total funding,. See insights on Invectys including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Invectys, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
About Invectys Inspired by ideas from the world-renowned Pasteur Institute in Paris, Invectys, Inc. has two wholly owned subsidiaries, Invectys, S.A.S (Paris), which is focused on scientific …See details»
Invectys - Cancer Immunotherapeutics
Technology: Founded in 2010 out of the Pasteur Institute, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer with its headquarters in Houston, …See details»
Organization | Invectys
Invectys Report issue For profit Phase 2 Founded: Paris France (2010) Status: Left NME R&D (2023) Organization Overview First Clinical Trial 2014 NCT02301754 First Marketed Drug …See details»
Invectys - Overview, News & Similar companies | ZoomInfo.com
View Invectys (www.invectys.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Invectys 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Invectys. Use the PitchBook Platform to explore the full profile.See details»
Company - Invectys
About Invectys Inc. Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. …See details»
Invectys Therapeutics - Leadership Team | The Org
The Leadership Team at Invectys Therapeutics is responsible for setting the strategic direction and vision of the company, overseeing the development of innovative immunotherapy …See details»
Invectys - VentureRadar
"Invectys develops a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys …See details»
Senior Management Team - Invectys
Invectys Inc. is led by a team of experienced industry professionals, combining vision, scientific knowledge and management skills. Dr. Jake Kushner, President & CEO, Invectys Inc. Dr. Jake …See details»
Invectys SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Invectys SAS with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Immune System Diseases, Hemic and Lymphatic Diseases, …See details»
Invectys Therapeutics - Contacts, Employees, Board Members, …
Invectys Therapeutics is a biopharmaceutical company focused on the development of immunotherapy approaches to treat cancer.See details»
Invectys - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 23, 2025 Invectys is a series A company based in Paris (France), founded in 2010. It operates as a Telomerase-based therapeutic vaccines for cancer. Invectys has raised $22.5M …See details»
Mission and vision - Invectys
Invectys’ vision Invectys develops novel approaches to mobilize and restore the anti-tumor capacity of the immune system of cancer patients, by targeting a broad-ranging cancer …See details»
Presentation - Invectys
May 26, 2023 Presentation Founded in 2010 out of the Pasteur Institute, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy …See details»
Products & pipeline Archives - Invectys
Founded in 2010 out of the Pasteur Institute, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer with its …See details»